AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2015
Feb 27, 2015
30339_dirs_2015-02-27_780bf24b-e88c-4929-97ec-40e44240c457.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-02-27
Reporting Person: LUZZI RICHARD D (Sr. VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-27 | Common Stock | M | 10000.0000 | $20.8500 | Acquired | 100723.6800 | Direct |
| 2015-02-27 | Common Stock | S | 10000.0000 | $54.8500 | Disposed | 90723.6800 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-27 | Stock Option (Right to Buy) | $20.8500 | M | 10000.0000 | Disposed | 2018-02-26 | Common Stock (10000.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 962.1160 | Indirect |
| Common Stock | 9251.9704 | Indirect |
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12